Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 4 results.
User Information
Export Records
  1. 1.   First-in-human phase 0 study of 111In-CHX-A"-DTPA trastuzumab for HER2 tumor imaging
  2. Kurdziel, K A; Mena, E; McKinney, Y; Wong, K; Adler,Stephen; Sissung, T; Lee, J; Lipkowitz, S; Lindenberg, L; Turkbey, B; Kummar, S; Milenic, D E; Doroshow, J H; Figg, W D; Merino, M J; Paik, C H; Brechbiel, M W; Choyke, P L
  3. Journal of translational science. 2019, Apr; 5(2):
  1. 2.   Chromatographic methods for the quantification of free and chelated gadolinium species in MRI contrast agent formulations
  2. Clevel, D.; Long, S. E.; Sander, L. C.; Davis, W. C.; Murphy, K. E.; Case, R. J.; Rimmer, C. A.; Francini, L.; Patri, A. K.
  3. Analytical and Bioanalytical Chemistry. 2010, Dec; 398(7-8): 2987-2995.
  1. 3.   Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates
  2. Nwe, K.; Bernardo, M.; Regino, C. A. S.; Williams, M.; Brechbiel, M. W.
  3. Bioorganic & Medicinal Chemistry. 2010, Aug; 18(16): 5925-5931.
  1. 4.   A dual CT-MR dendrimer contrast agent as a surrogate marker for convection-enhanced delivery of intracerebral macromolecular therapeutic agents
  2. Regino, C.; Walbridge, S.; Bernardo, M.; Wong, K. J.; Johnson, D.; Lonser, R.; Oldfield, E. H.; Choyke, P. L.; Brechbiel, M. W.
  3. Contrast Media & Molecular Imaging. 2008 3(1): 2-8.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel